Sana Biotechnology SANA
NASDAQ SANA
$3.02 +0.10 (+3.43%)
As of: Oct 1, 2026 · 1:15 PM EDT

Sana Biotechnology (SANA) Total Non-Current Liabilities (2020 - 2026)

Updated

Sana Biotechnology's Total Non-Current Liabilities came in at $177.35 million for Q2 2026, up 45.4% from $121.96 million a year earlier and up 3.6% from the prior quarter.

Analysis

Sana Biotechnology (SANA) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Sana Biotechnology's Total Non-Current Liabilities was $172.49 million, up 21.9% from FY2024.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of -30.0% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $141.55 million in FY2024 (-15.8%), $168.19 million in FY2023 (-26.4%), $228.37 million in FY2022 (-23.5%) and $298.54 million in FY2021 (-71.0%).
  • The Q2 2026 figure represents the highest quarterly Total Non-Current Liabilities since Q1 2024.
  • Year-over-year, Total Non-Current Liabilities has increased for three consecutive quarters, with growth averaging 0.3% over the last eight quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q2 2026 (growth of 45.4%), and the weakest in Q4 2021 (a decline of 71.0%).
  • Business Quant data shows SANA's Total Non-Current Liabilities at $171.15 million (Q1 2026), $172.49 million (Q4 2025) and $124.98 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Sana Biotechnology 870.98 Mn 870.98 Mn - 177.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 177.35 Mn
Mar 31, 2026 171.15 Mn
Dec 31, 2025 172.49 Mn
Sep 30, 2025 124.98 Mn
Jun 30, 2025 121.96 Mn
Mar 31, 2025 125.56 Mn
Dec 31, 2024 141.55 Mn
Sep 30, 2024 155.06 Mn
Jun 30, 2024 167.40 Mn
Mar 31, 2024 191.25 Mn
Dec 31, 2023 168.19 Mn
Sep 30, 2023 162.43 Mn
Jun 30, 2023 241.62 Mn
Mar 31, 2023 214.07 Mn
Dec 31, 2022 228.37 Mn
Sep 30, 2022 250.38 Mn
Jun 30, 2022 233.59 Mn
Mar 31, 2022 243.64 Mn
Dec 31, 2021 298.54 Mn
Sep 30, 2021 314.14 Mn
API Access

Sana Biotechnology Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SANA&period=max&api_key=YOUR_API_KEY